德康医疗Connect研究,作为一项具有里程碑意义的临床研究,为非胰岛素治疗的2型糖尿病患者展示了持续葡萄糖监测(CGM)的显著益处。这项研究提供了迄今为止最有力的临床证据,证实了CGM技术在这一庞大患者群体中的应用价值。
德康医疗Connect研究,作为一项具有里程碑意义的临床研究,为非胰岛素治疗的2型糖尿病患者展示了持续葡萄糖监测(CGM)的显著益处。这项研究提供了迄今为止最有力的临床证据,证实了CGM技术在这一庞大患者群体中的应用价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.